Manish K. Pant
Experienced in Chronic B-Cell Leukemia (CBCL)

Dr. Manish K. Pant

Hematology | Oncology
Aurora Healthcare
Aurora Cancer Care
2801 W Kinnickinnic River Pkwy, Ste 980, 
Milwaukee, WI 
On Staff At
Offers Telehealth

Experienced in Chronic B-Cell Leukemia (CBCL)
Aurora Healthcare
Aurora Cancer Care
2801 W Kinnickinnic River Pkwy, Ste 980, 
Milwaukee, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Manish Pant is a Hematologist and an Oncologist in Milwaukee, Wisconsin. Dr. Pant is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Alveolar Soft Part Sarcoma, and Adult Soft Tissue Sarcoma.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
George Washington University, Internal Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in WI
Board Certifications
American Board Of Internal Medicine, Hematology
Fellowships
George Washington University, Hematology/Oncology
Hospital Affiliations
Aurora St Lukes Medical Center
Aurora Medical Center
West Allis Memorial Hospital
Aurora Medical Center - Summit
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Common Ground Healthcare
  • OTHER COMMERCIAL
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Icare Independent Care Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Network Health
  • HMO
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Aurora Cancer Care
2801 W Kinnickinnic River Pkwy, Ste 980, Milwaukee, WI 53215
Call: 414-384-5111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
A Phase Ib Trial of Neoadjuvant AMG 232 (KRT-232) Concurrent With Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)
A Phase Ib Trial of Neoadjuvant AMG 232 (KRT-232) Concurrent With Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drug: MDM2 Inhibitor KRT-232
Study Phase: Phase 1
A Phase II Randomized Study of Nivolumab (NSC-748726) With Ipilimumab (NSC-732442) or Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD1 or Anti-PD-L1 Agent
A Phase II Randomized Study of Nivolumab (NSC-748726) With Ipilimumab (NSC-732442) or Ipilimumab Alone in Advanced Melanoma Patients Refractory to an Anti-PD1 or Anti-PD-L1 Agent
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
View 3 Less Clinical Trials

2 Total Publications

Advances in systemic therapies for metastatic castration-resistant prostate cancer.
Advances in systemic therapies for metastatic castration-resistant prostate cancer.
Journal: Future oncology (London, England)
Published: December 05, 2014
View All 2 Publications
Similar Doctors
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Ehab L. Atallah
Hematology Oncology | Oncology | Hematology
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Ehab L. Atallah
Hematology Oncology | Oncology | Hematology

The Medical College Of Wisconsin Inc

4805 S Moorland Rd, 
New Berlin, WI 
 (8.4 miles away)
262-798-7700
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Ehab Atallah is a Hematologist Oncology specialist and an Oncologist in New Berlin, Wisconsin. Dr. Atallah is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Atallah is currently accepting new patients.

Malik T. Bandealy
Advanced in Chronic B-Cell Leukemia (CBCL)
Dr. Malik T. Bandealy
Hematology | Oncology
Advanced in Chronic B-Cell Leukemia (CBCL)
Dr. Malik T. Bandealy
Hematology | Oncology

Vince Lombardi Cancer Clinic

6811 118th Ave, 
Kenosha, WI 
 (28.8 miles away)
262-857-5750
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Offers Telehealth

Malik Bandealy is a Hematologist and an Oncologist in Kenosha, Wisconsin. Dr. Bandealy is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Thrombocytopenia, and Adult Immune Thrombocytopenia.

Michael P. Mullane
Advanced in Chronic B-Cell Leukemia (CBCL)
Dr. Michael P. Mullane
Hematology | Oncology
Advanced in Chronic B-Cell Leukemia (CBCL)
Dr. Michael P. Mullane
Hematology | Oncology

Aurora Cancer Care

8400 Washington Ave, Ste 203, 
Racine, WI 
 (18.9 miles away)
262-884-8340
Languages Spoken:
English
See accepted insurances

Michael Mullane is a Hematologist and an Oncologist in Racine, Wisconsin. Dr. Mullane is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

VIEW MORE CHRONIC B-CELL LEUKEMIA (CBCL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pant's expertise for a condition
ConditionClose
    • Distinguished
    • Adult Soft Tissue Sarcoma
      Dr. Pant is
      Distinguished
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Alveolar Soft Part Sarcoma
      Dr. Pant is
      Distinguished
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Desmoplastic Small Round Cell Tumor
      Dr. Pant is
      Distinguished
      . Learn about Desmoplastic Small Round Cell Tumor.
      See more Desmoplastic Small Round Cell Tumor experts
    • Rhabdoid Tumor
      Dr. Pant is
      Distinguished
      . Learn about Rhabdoid Tumor.
      See more Rhabdoid Tumor experts
    • Rhabdoid Tumor Predisposition Syndrome
      Dr. Pant is
      Distinguished
      . Learn about Rhabdoid Tumor Predisposition Syndrome.
      See more Rhabdoid Tumor Predisposition Syndrome experts
    • Rhabdomyosarcoma
      Dr. Pant is
      Distinguished
      . Learn about Rhabdomyosarcoma.
      See more Rhabdomyosarcoma experts
    View All 8 Distinguished Conditions
    • Advanced
    • Angiosarcoma
      Dr. Pant is
      Advanced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Bone Tumor
      Dr. Pant is
      Advanced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Cervical Cancer
      Dr. Pant is
      Advanced
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Epithelioid Sarcoma
      Dr. Pant is
      Advanced
      . Learn about Epithelioid Sarcoma.
      See more Epithelioid Sarcoma experts
    • Fibrosarcoma
      Dr. Pant is
      Advanced
      . Learn about Fibrosarcoma.
      See more Fibrosarcoma experts
    • Ganglioneuroblastoma
      Dr. Pant is
      Advanced
      . Learn about Ganglioneuroblastoma.
      See more Ganglioneuroblastoma experts
    View All 17 Advanced Conditions
    • Experienced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Pant is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Pant is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Pant is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Acute Promyelocytic Leukemia
      Dr. Pant is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Adult Immune Thrombocytopenia
      Dr. Pant is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Pant is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    View All 52 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.